Clinical Trial Update: Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating a humanized CD7 CAR T-cell therapy for relapsed/refractory CD7+ acute leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Phenotype Acute Leukemia
• T-lymphoblastic Leukemia Lymphoma

Drugs mentioned

• CD7 CAR T-cell therapy (humanized) (CD7 CAR T-cell therapy)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: T Lymphoblastic Leukemia/Lymphoma, Mixed Phenotype Acute Leukemia | Phase 1, Phase 2 | Status: UNKNOWN